Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Net Sales	$ 7,932.9	$ 7,803.3	$ 7,668.4
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 2,271.9	$ 2,132.9	$ 2,381.8
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 595.9	$ 603.9	$ 565.9
Research and development	391.7	369.9	365.6
Selling, general and administrative	3,379.3	3,104.7	2,944.6
Goodwill and intangible asset impairment	979.7	331.5	31.1
Acquisition, integration and related	133.7	279.8	504.9
Quality remediation	146.9	181.3	53.4
Operating expenses	7,899.1	7,004.0	6,847.3
Operating Profit	33.8	799.3	821.1
Other expense, net	(15.6)	(9.4)	(66.5)
Interest expense, net	(289.3)	(325.3)	(355.0)
(Loss) earnings before income taxes	(271.1)	464.6	399.6
Provision (benefit) for income taxes	108.2	(1,348.8)	95.0
Net (Loss) Earnings	(379.3)	1,813.4	304.6
Less: Net loss attributable to noncontrolling interest	(0.1)	(0.4)	(1.3)
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	$ (379.2)	$ 1,813.8	$ 305.9
(Loss) Earnings Per Common Share - Basic	$ (1.86)	$ 8.98	$ 1.53
(Loss) Earnings Per Common Share - Diluted	$ (1.86)	$ 8.90	$ 1.51
Weighted Average Common Shares Outstanding
Basic	203.5	201.9	200.0
Diluted	203.5	203.7	202.4